How do you build an AI-native R&D organization without losing the scientific judgment that makes drug development possible?
Andy Plump, President of Research & Development at Takeda, joins David Berry on Averin Insights to discuss how technology is changing drug discovery and development.
They explore the role of basic science, the changing global research landscape, and how R&D leaders can combine speed, technology, and clinical understanding to bring new medicines to patients.
